Kinetic analysis of the accumulation of a half-sandwich organo-osmium pro-drug in cancer cells. A. Ballesta*, F. Billy, J.P.C. Coverdale, J-I. Song, C. Sanchez-Cano, I. Romero-Canelón* and P.J. Sadler* Metallomics, 2019, 11, 1648-1656.
Designing ruthenium anticancer drugs: what have we learnt from the key drug candidates? J.P.C. Coverdale, T. Laroiya-McCarron and I. Romero-Canelón*, Inorganics, 2019, 7, 31-42.
In vivo selectivity and localization of reactive oxygen species (ROS) induction by osmium anticancer complexes that circumvent platinum-resistance. J.P.C. Coverdale, H.E. Bridgewater, J-I. Song, N.A. Smith, N.P.E. Barry, I. Bagley, P.J. Sadler and I. Romero-Canelón*, J. Med. Chem. 2018, 61, 9246-9255.
Asymmetric transfer hydrogenation by synthetic catalysts in cancer cells. J. P. C. Coverdale, I. Romero-Canelón, C. Sanchez-Cano, G. J. Clarkson, A. Habtemariam, M. Wills and P. J. Sadler. Nat. Chem. 2017, 10, 347-354.
Systems approach to metal-based pharmacology. I. Romero-Canelón and P.J. Sadler. Proc. Natl. Acad. Sci. USA. 2015, 112, 4187-4188.